Steven M Johnson
Overview
Explore the profile of Steven M Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
3891
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lewis J, Arens D, Quaye A, Calvopina-Chavez D, Jensen K, Miller A, et al.
Microbiol Resour Announc
. 2024 Dec;
14(1):e0083623.
PMID: 39688389
We announce the complete genomes of phages ValerieMcCarty03 and ValerieMcCarty04 isolated from wastewater treatment plant samples that infect a multidrug-resistant clinical isolate. These phages belong to the T4-like cluster and...
2.
Gal J, Johnson S
ACS Omega
. 2024 Aug;
9(33):35243-35255.
PMID: 39184464
The CH-π bonding potential of a saccharide is determined primarily by the number of hydrogen atoms available for bonding and is reduced by side groups that interfere with the CH-π...
3.
Godek J, Sivinski J, Watson E, Lebario F, Xu W, Stevens M, et al.
J Am Chem Soc
. 2024 Jul;
146(30):20845-20856.
PMID: 39041457
We recently reported on small-molecule inhibitors of the GroES/GroEL chaperone system as potential antibiotics against and the ESKAPE pathogens but were unable to establish GroES/GroEL as the cellular target, leading...
4.
Kandahari N, Johnson S, Thorp B
Laryngoscope
. 2024 May;
134(9):4023-4027.
PMID: 38752647
The differential for an ill-defined, bone-destructive, granulomatous lesion of the skull base includes malignancy, as well as autoimmune and infectious processes. Suspicion for tuberculosis of the skull base in high-risk...
5.
Kim H, Byun D, Thakur K, Ritchie J, Xie Y, Holewinski R, et al.
ACS Chem Biol
. 2024 Apr;
19(5):1082-1092.
PMID: 38629450
Electrophilic small molecules with novel reactivity are powerful tools that enable activity-based protein profiling and covalent inhibitor discovery. Here, we report a reactive heterocyclic scaffold, 4-chloro-pyrazolopyridine (CPzP) for selective modification...
6.
Matson B, Evron J, Johnson S, Zeitler E, Klein K
JCEM Case Rep
. 2024 Mar;
2(3):luae034.
PMID: 38440127
Here, we present the case of a 40-year-old man in whom the diagnosis of ectopic adrenocorticotropin (ACTH) syndrome went unrecognized despite evaluation by multiple providers until it was ultimately suspected...
7.
Johnson S, Haberberger J, Galeotti J, Ramkissoon L, Coombs C, Richardson D, et al.
Leuk Lymphoma
. 2023 Nov;
65(2):209-218.
PMID: 37921062
A large-scale genomic analysis of patients with -mutated myeloid disease has not been performed to date. We reviewed comprehensive genomic profiling results from 6043 adults to characterize clinicopathologic features and...
8.
Rai R, Dawodu O, Johnson S, Vilseck J, Kelley M, Ziarek J, et al.
bioRxiv
. 2023 Jul;
PMID: 37425839
Targeting of the multifunctional enzyme apurinic/apyrimidinic endonuclease I/redox factor 1 (APE1) has produced small molecule inhibitors of both its endonuclease and redox activities. While one of the small molecules, the...
9.
Patel S, Gibson M, Deal A, Sheth S, Heiling H, Johnson S, et al.
Cancer
. 2023 Jul;
129(21):3381-3389.
PMID: 37395170
Background: Patients with locally advanced head and neck squamous cell cancer (HNSCC) are treated with surgery followed by adjuvant (chemo) radiotherapy or definitive chemoradiation, but recurrence rates are high. Immune...
10.
Johnson S, Haberberger J, Galeotti J, Ramkissoon L, Coombs C, Richardson D, et al.
Blood Cancer J
. 2023 Jun;
13(1):96.
PMID: 37365170
No abstract available.